ArticlePloS one2026
Sepsis neonatorum: Bacterial profile, antimicrobial resistance patterns, among neonates and associated factors, Dilla University Referral Hospital, southern Ethiopia, with special reference to WHO prioritized pathogens.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis neonatorum (neonatal sepsis) constitutes severe, life-threatening infections, frequently necessitating intensive care unit admissions, and is a leading indication for antibiotic prescription in neonatal clinical practices. In Ethiopia, neonatal sepsis is quite rampant, and the widespread empirical therapy results in several interrelated challenges, such as incorrect or misuse of antibiotics, bacterial virulence, and aggravation of drug resistance and treatment failures.
aimsThis study was done to assess the culture-positive sepsis, antibiotic susceptibility patterns, and associated factors among neonates attending Dilla University Referral Hospital, southern Ethiopia.
methodsA cross-sectional study was conducted from August to October 2023 among 280 neonates suspected of sepsis using systematic random sampling. Data and venous blood samples were collected and analyzed using standard microbiological procedures. Antibiotic susceptibility was tested by Kirby-Bauer disk diffusion. SPSS and logistic regression were used for analysis, with p ≤ 0.05 considered statistically significant.
resultsThe overall culture-positive prevalence (n = 88) of neonatal sepsis was 31.4% (95% CI: 25.7, 36.8). Neonatal sepsis was predominantly caused by Escherichia coli (n = 27, 30.7%), followed by Klebsiella pneumoniae (n = 18, 20.5%). Both Gram-negative and Gram-positive bacteria were extremely resistant (80-100%) to ampicillin, amoxicillin-clavulanate, ceftriaxone, and ceftazidime. Overall, 70.2% of the isolates were multi-drug resistant, including more than a quarter of isolates that were WHO prioritized, viz., methicillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase bacteria. Isolates exceeding one-fourth of the entire bacteria studied demonstrated resistance to both the first- and second-line regimens. Residence in rural areas [AOR: 1.43; 95% CI: 1.22-5.84 (p < 0.05)], mode of delivery by Caesarean section [AOR: 3.23; 95% CI: 1.04-9.46 (p < 0.002)], lengthy hospital stays [AOR: 4.65; 95% CI: 1.55-13.9 (p < 0.001)], prolonged labour [AOR: 3.36; 95% CI: 1.32-8.56 (p < 0.05)], and preterm premature rupture of membrane [AOR: 5.23; 95% CI: 4.11-9.49 (p < 0.001)] were statistically associated with the outcome.
conclusionsA substantial prevalence of culture-confirmed cases of neonatal sepsis was identified, in comparison to other regions of the country. Alarmingly, bacterial isolates demonstrated considerable resistance to the first-and second-line regimens. Regular monitoring of antibiotic resistance patterns and timely implementation of enhanced infection prevention strategies are the need of the hour.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.